Frontlight ResearchEarly access
Trial site
HonorHealth Research and Innovation Institute
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Head and neck cancer3 trials
- Melanoma3 trials
- Cervical cancer2 trials
- Coronary artery disease1 trial
- Lung cancer1 trial
- Lupus (SLE)1 trial
- Ovarian cancer1 trial
- Rheumatoid arthritis1 trial
- Sarcoma1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 12 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- TScan Therapeutics, Inc.2 trials
- Amgen1 trial
- Kardion Inc1 trial
- SparX Biotech(Jiangsu) Co., Ltd.1 trial
- Strand Therapeutics Inc.1 trial
Running trials
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Recruiting
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
Active, not recruiting
Recruiting
Recruiting
A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coronary artery disease1 recruiting
- Head and neck cancer1 recruiting
- Lupus (SLE)1 recruiting
- Melanoma1 recruiting
- Rheumatoid arthritis1 recruiting
- Triple-negative breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026